World

Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization

Pfizer said on Wednesday there had been 170 cases of the disease in its trial of more than 43,000 volunteers, of which 162 were observed in the placebo arm and 8 were in the vaccine group.Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization
 Reuters
bookmark
Reuters
Published at : November 18, 2020
Updated at : January 6, 2021 14:47

×
Top